Back to search

Article

Optimizing Testing Time for Methaemoglobin Reduction Test in G6PD Screening: A Comparative Experimental Study between the Monica Cheesbrough Protocol and the Asutifi North District Hospital Protocol at Asutifi North District Hospital, Ghana.

2024-10-30

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an inherited disorder caused by a genetic defect in the red blood cell enzyme G6PD, affecting around 500 million people worldwide. The study investigated the optimum methaemoglobin reduction test (MRT) reaction time for diagnosing G6PD deficiency among patients at Asutifi North District Hospital using Monica...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
912b00fd-7458-5695-ac38-3c07028d9d3d
DOI
10.21203/rs.3.rs-5294971/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Optimizing Testing Time for Methaemoglobin Reduction Test in G6PD Screening: A Comparative Experimental Study between the Monica Cheesbrough Protocol and the Asutifi North District Hospital Protocol at Asutifi North District Hospital, Ghana.DOI 10.21203/rs.3.rs-5294971/v1
Diagnostic accuracy of the Point-of-Care Standard G6PD test™ (SD Biosensor) for Glucose-6-phosphate dehydrogenase deficiency: a systematic review of the literatureSemantic proximity
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in MauritaniaSemantic proximity
Exploring Appropriate Reference Intervals and Clinical Decision Limits for Glucose-6-Phosphate Dehydrogenase Activity in Individuals From Guangzhou, China.Semantic proximity
Quantitative G6PD point-of-care test can be used reliably on cord blood to identify male and female newborns at increased risk of neonatal hyperbilirubinaemia: a mixed method studySemantic proximity
A Precision Screening Framework for Thalassemia in a High-Mobility Population: Integrating 3D Phenotypic Mapping and Genotype-Specific ThresholdsSemantic proximity
Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiencySemantic proximity
Integrated Phenotypic and Genotypic Approaches for Accurate Diagnosis of G6PD Deficiency: Implications for Drug Safety in ThailandSemantic proximity
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.Semantic proximity
Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, BangladeshSemantic proximity
Assessment of Glucose-6 phosphate dehydrogenase deficiency in malaria suspected patients attending at Shele and Lante Health Center, Southern EthiopiaSemantic proximity
Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.Semantic proximity
Effects of Buffer Substitution on Rapid Diagnostic Tests for Malaria DiagnosisSemantic proximity
Select a neighboring publication to make it the new centre.